Zacks Research Predicts Neogen’s Q3 Earnings (NASDAQ:NEOG)

Neogen Corporation (NASDAQ:NEOG) – Investment analysts at Zacks Research dropped their Q3 2026 earnings estimates for Neogen in a report released on Thursday, January 29th. Zacks Research analyst Team now forecasts that the company will post earnings of $0.04 per share for the quarter, down from their prior forecast of $0.07. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen’s FY2026 earnings at $0.24 EPS, Q1 2027 earnings at $0.06 EPS, Q4 2027 earnings at $0.05 EPS and Q2 2028 earnings at $0.08 EPS.

Several other equities analysts also recently weighed in on NEOG. Weiss Ratings reiterated a “sell (e+)” rating on shares of Neogen in a research report on Monday, December 29th. Wall Street Zen downgraded shares of Neogen from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Piper Sandler reiterated a “neutral” rating and set a $10.00 price objective (up from $6.50) on shares of Neogen in a report on Monday, January 12th. CJS Securities upgraded shares of Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 target price for the company in a report on Wednesday, December 10th. Finally, Guggenheim reaffirmed a “buy” rating and set a $12.00 price target (up previously from $8.00) on shares of Neogen in a research report on Friday, January 9th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $10.67.

Neogen Trading Up 0.3%

Shares of Neogen stock opened at $10.25 on Monday. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $11.23. The business’s fifty day moving average is $7.82 and its two-hundred day moving average is $6.42. The company has a quick ratio of 2.80, a current ratio of 3.91 and a debt-to-equity ratio of 0.38. The firm has a market cap of $2.23 billion, a PE ratio of -3.70 and a beta of 1.96.

Neogen (NASDAQ:NEOG) last announced its earnings results on Thursday, January 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. The firm had revenue of $224.69 million for the quarter, compared to analyst estimates of $208.50 million. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. Neogen’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.11 earnings per share.

Institutional Investors Weigh In On Neogen

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in shares of Neogen by 1.6% in the 3rd quarter. Vanguard Group Inc. now owns 23,963,223 shares of the company’s stock valued at $136,830,000 after acquiring an additional 385,885 shares during the period. ING Groep NV acquired a new stake in Neogen in the 3rd quarter valued at $80,288,000. Clarkston Capital Partners LLC raised its position in Neogen by 123.2% in the second quarter. Clarkston Capital Partners LLC now owns 14,005,725 shares of the company’s stock valued at $66,947,000 after purchasing an additional 7,729,650 shares during the period. Norges Bank purchased a new position in Neogen in the second quarter valued at about $43,387,000. Finally, Mackenzie Financial Corp lifted its stake in shares of Neogen by 0.7% during the second quarter. Mackenzie Financial Corp now owns 7,813,079 shares of the company’s stock worth $37,347,000 after purchasing an additional 54,590 shares in the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.